Apr 29,2021

Kaia Health lands $75M Series C on soaring demand for virtual therapies

Digital therapeutics company Kaia Health has raised $75 million in series C funding on surging demand for digital musculoskeletal services. Kaia Health uses machine learning (ML) to offer individualized care through apps, which let patients self-manage conditions such as back pain, chronic obstructive pulmonary disease (COPD) and osteoarthritis. An unnamed investor led the funding round and existing investors such as Optum Ventures, Eurazeo, capital300 and Symphony Ventures, the investment company of golfer Rory McIlroy, also participated.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
May 04,2021

UK healthtech company my mhealth and collaborators awarded €2.5M Eurostars Grant

NHS-approved digital therapeutics company, my mhealth, along with three European collaborators, have been awarded a €2.5 million Eurostars Grant for the development of their project, CUOREMA. Eurostars is a European joint programme, co-funded from the national budgets of 36 EUREKA countries and by the European Union through Horizon 2020. Innovate UK will also sponsor my mhealth to develop part of its myHeart app to support cardiac rehabilitation in Europe.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
May 26,2021

PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, today announced that its Founded Entity, Akili Interactive (“Akili”), has secured $160 million of combined equity and debt financing. The financing included a $110 million Series D equity financing round led by Neuberger Berman Funds and joined by new investors Polaris Partners, Mirae Assets, Shionogi & Co., Ltd., New Leaf Venture Partners, Dave Baszucki (Founder and CEO of Roblox Corporation), QUAD Investment Management, and Ladera Venture Partners. This funding will support a go-to market approach that brings EndeavorRx to families and healthcare professionals at scale and expand Akili’s global footprint within attention-deficit/hyperactivity disorder (ADHD) and beyond.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Jun 16,2021

Ksana Health Secures $2M Seed Round to Launch Advanced Mental Health Monitoring Platform

Ksana Health, a digital health company dedicated to revolutionizing behavioral healthcare and research through objective measurement and monitoring, announced today that it has raised $2M in seed funding led by Christian Angermayer’s re.Mind Capital. Separately, Ksana Health accepted an invitation from Anthem to join the Anthem Digital Incubator to pilot Ksana Health’s new digital health solution, Vira.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 08,2021

MindMaze scores $125M for game-like rehab treatment

Digital neurotherapeutic platform MindMaze has raised $125 million in funding from AlbaCore Capital Group. The company said it will use the new funds to speed commercialization and access to its rehab products, especially in North America and Europe. The capital will also allow it to expand its restorative products aimed at repairing brain damage, via more development and testing in clinical trials.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 13,2021

Lark Health Raises $100 Million Series D Funding Round Led by Deerfield Management

Lark Health today announced that it has closed a $100 million Series D funding round led by Deerfield Management Company. The funding round also includes crossover fund PFM Health Sciences, as well as returning investors Franklin Templeton Investments, King River Capital, Castle Peak Partners, IPD Capital, Olive Tree Capital, and Marvell Technology cofounder Weili Dai.

FUNDING SERIES D
View Analyst & Ambassador Comments
Go to original news
Oct 22,2021

DTx company Click Therapeutic scores $52M in Series B funding

This morning prescription digital therapeutic company Click Therapeutic announced a $52 million Series B funding round. H.I.G. BioHealth Partners and Accelmed Partners ll led the round, with participation from Health Catalyst Capital, Revelation Partners, Sanofi, K2 HealthVentures, Hima Ventures and RdigetopHealth. This news comes over a year after the company inked a $500 million-plus deal with pharma company Boehringer Ingelheim to jointly commercialize a digital treatment for patients with schizophrenia.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 28,2021

MSK startup Hinge Health lands $600M in new investments

Digital musculoskeletal (MSK) health company Hinge Health has raised a whopping $400 million in a Series E funding round led by Tiger Global and Coatue Management. Alkeon and Whale Rock also put in a $200 million secondary investment to acquire ownership in Hinge. Along with the funding, Hinge also announced two new hires: Lalith Vadlamannati will serve as chief technology officer after spending 13 years at Amazon, and Vincent Lim was hired as chief HR officer, coming from human resources at Google, Medium and JUUL Labs.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Oct 29,2021

Better Therapeutics Closes Business Combination and Debuts on Nasdaq

Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (Nasdaq: MCAD; “Mountain Crest II”), a publicly traded special purpose acquisition corporation or SPAC. The transaction generated approximately $70 million in gross proceeds from the business combination, a private investment in a public equity (PIPE) from leading healthcare investors led by Farallon Capital Management, RS Investments, Sectoral Asset Management, and Monashee Investment Management. The proceeds of the transaction will be used to advance Better Therapeutics’ lead product for the treatment of type 2 diabetes, BT-001, through clinical trials and submission for marketing authorization by the FDA, and to advance its PDT pipeline for other cardiometabolic conditions.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Nov 11,2021

AppliedVR scores $36M for virtual reality pain management

AppliedVR, developer of virtual reality therapeutics, has scooped up $36 million in Series B funding months after it closed a Series A round. The Series B, which included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures, brought the company’s total raise to $71 million. AppliedVR creates virtual reality technology for healthcare applications, with platforms in its pipeline for chronic pain management, acute postoperative pain and anxiety.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING